Pioneering Gut Science, Kintai Therapeutics Is Bringing a New Small Molecule Modality to Fruition
What if the gut, widely regarded as the body’s second brain, could offer a much more impactful means to effect broad systemic pharmacological actions of orally administered drugs based on the confluence of the enteric nervous system, immune system, and microbiome within it?
